Form 4: Tevogen Bio Holdings Director Goh Keow Lin Receives 240,000 Restricted Stock Units

Director Goh Keow Lin of Tevogen Bio Holdings Inc. was granted 240,000 restricted stock units (RSUs) that will vest over four years.

Summary

• Goh Keow Lin, a director at Tevogen Bio Holdings Inc., received 240,000 restricted stock units (RSUs) on December 23, 2024.
• These RSUs were granted under the company's 2024 Omnibus Incentive Plan.
• The RSUs will vest in four equal annual installments, starting on January 1, 2025.
• Vesting is contingent upon Goh Keow Lin remaining in service with the company on the vesting dates.
• Each RSU represents the right to receive one share of Tevogen Bio Holdings Inc.'s common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating a positive but not extraordinary event. The vesting schedule suggests a long-term commitment, which is generally viewed favorably.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Risks

• The vesting of the RSUs is contingent on the director's continued service with the company, which introduces a risk of forfeiture if the director leaves before full vesting.

Future Outlook

The RSUs will vest over the next four years, contingent on the director's continued service.

Industry Context

The use of restricted stock units is a common practice in the biotechnology industry to incentivize and retain key personnel.

Comparison to Industry Standards

• The use of RSUs for director compensation is a standard practice in the biotech industry, similar to companies like Moderna and BioNTech, which also use equity-based incentives.
• The four-year vesting schedule is also typical, aligning with long-term value creation goals, similar to vesting schedules seen at companies like Regeneron and Gilead Sciences.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the director to contribute to the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Next Steps

• The RSUs will continue to vest annually on January 1st for the next four years, provided the director remains in service.

Key Dates

Keywords

restricted stock units, RSUs, stock grant, director, Tevogen Bio Holdings, equity compensation, vesting